chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever (103.5). Limb pain/swelling/color (Rt deltoid). Lymphadenopathy. Fatigue. Muscle/joint pain. Headache. Increased PBS. Symptoms began < 24 hrs after injection. Seen in local ER 2 days later.
Client came in for second dose Moderna COVID-19 vaccine at 4 week interval.  Pfizer COVID-19 vaccine was inadvertantly administered for second dose instead of Moderna.  Error was caught within 5 minutes while client was waiting after injection.  No adverse events were noted in 20 minutes following.  Pfizer COVID-19 vaccine EUA was given and read by client.  Informed from CDC guidance to not repeat second dose of either product at this time.
On 10/18/2021 client returned for vaccine number two of Moderna.  It was discovered at that time that she should have not received Moderna,  Pfizer was age appropriate.  Mother and Father were informed.  Mother was asked if client had adverse reaction she said, yes.  Was asked if it was fever,chills and aches and she said,yes.  Mother was informed that was a normal immune response to a vaccine.  Parents were informed that the CDC was called and they suggested giving a 2nd Moderna vaccine and report the event to VAERs.  Parents were given a written copy CDC's suggestion along with CDC's number and information on how to contact VAERs.
Pt in ER with an occluded left common femoral artery and origin of the left superficial femoral artery.  Occluded left popliteal artery, anterior tibial artery, posterior tibial artery and peroneal artery.  Placed on heparin drip
Patient was vaccinated on 2-4-11 on 3-3-11 AM - patient complain soreness on left arm and discomfort when moving arm. Also sensitive when putting shirt with sleeve on. She has some soreness & aching for a few days after vaccination but it is more severe now. There is a lump at injection site.
no adverse effect; multiple patients were vaccinated with improperly stored VAQTA on multiple dates; This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 14-MAR-2019, the patient was vaccinated with improperly stored hepatitis a vaccine, inactivated(VAQTA) lot # R027431, expiry date 25-MAR-2019 for prophylaxis.  No adverse event was reported. Previous temperature excursion was reported. Data logger was involved.
flu every time; Initial information received on 19-Nov-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional via social media.  This case involves patient (unknown demographics) who experienced got the flu (influenza), while she received vaccine INFLUENZA VACCINE.  The patient's past vaccination included Influenza vaccine for prophylactic vaccination with reaction of Flu.  The patient's medical history, past medical treatment, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer and lot number not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious got the flu (influenza) (14 days) following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.   It was not reported if the patient received a corrective treatment.  The event outcome was unknown for influenza.  There will be no information available on the batch number for this case.
After 24 hours, tinnitus in left ear became severe for 20 hours; flared up again on day 7 and on day 9.  On day 9, my good ear (the right one) develooed low grade tinnitus .
Case completed 2 dose primary Covid series in March 2021, then was hospitalized for Covid in August of 2021.  * Acute hypoxemic respiratory failure due to COVID-19 Assessment & Plan Much improved, extubated 8/31, down to 1L of oxygen at rest, a few liters with exertion. Suspect mostly covid related at this point but acute chf likely contributed.  -Day 5 dexamethasone and baricitinib, held remdesivir due to elevated LFTs.  Upon discharge, will use dexamethasone alone for an additional 5 days to complete a total 10-day course -Discontinued abx for CAP a few days ago with no firm evidence of bacterial infection -Continue oral diuretics for CHF upon discharge -health department notified of the discharge and he will maintain isolation per their recommendation
A few months after receiving the shot I experienced weakness in my legs and headaches.  At first I was diagnosed with ADEM.  After 4 years I developed lesions and was diagnosed with having Multiple Sclerosis.  After being diagnosed with MS I began oral treatments.  My symptoms now are fatigue and headaches.
"Strep Thoat" Symptoms, itchy throat 25 mg PO Benadryl given BP 148/93 , HR 106, O2 sat 100% room air, RR 20
This spontaneous report was received from a physician who was informed by another physician via a company representative concerning to 21 year old patient of an unknown gender. There was no information about the patient's concurrent conditions, medical history or concomitant medication. On an unspecified date, the patient was vaccinated with a dose of GARDASIL for prophylaxis (strength, dose, route of administration, lot number and expiration date were not reported). It was reported that on an unknown date, the patient became "sterile" (Infertility) on an unspecified time after receiving the vaccine. The field representative stated that the physician may have learned of that event from reading an unspecified journal. There was no product quality complaint involved. The outcome of the event infertility and the causal relationship between the event and GARDASIL were not provided. Additional information has been requested.
I went to a specialist yesterday for my shoulder; I lifted up because I was nervous; shoulder pain; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EN6200, expiration date was not reported), via an unspecified route of administration on 22Feb2021 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that patient got her first shot on 22Feb2021 and she scheduled on this coming monday 15Mar2021 for her second Covid shot, she went to a specialist yesterday for her shoulder and she thought it was just a consult and if she needed to do it she can schedule it later after he talked with her he said Ok he is going to give her a Cortisone he left the room and she was on a therapy with her second shot and so when he came back in she told him and he said oh it won't interfere with it. So, he gave her the shot at last she got home and she lifted up because she was nervous, she was ok to get her second shot monday. He said it would not interfere the Pfizer Covid shot, so she was just nervous that she let him giving the shot and is it okay if she get the second shot of Covid. she was having shoulder pain, and call a specialist and said it will be a consult, so she went yesterday and She was given a steroid shot, and she asked the nurse if steroid will not affect with the vaccine and said that it won't affect it. So she looked it up online, and she know it is nothing sure, so she would want to know if it won't interfere with her vaccine for the 2nd shot on 15Mar2021. Therapeutic measures were taken as a result of shoulder pain. The outcome of the events was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Pt recvd vax & devel inj site rxn of redness, itching & soreness. Recovered p/1-2 days. Of 36 employees,20 females exp this event. 2 of the pt recovered p/4 days. Others not identifiable.
Received vaccine on 8/11/2021.  While in location for work, he experienced severe left leg pain and marked swelling on 9/7/2021.  He went to the emergency department and saw a physician assistant whose name he does not recall.  He had a blot clot diagnosed by ultrasound.  The PA told him "it's not a DVT but the clot is deeper than a superficial thrombophlebitis."  The area was markedly swollen, very tender, red and warm to the touch, and caused difficulty with walking.  4 days later it has substantially improved and is almost completely resolved at this point; swelling is gone, no redness, just tender.
ENLARGED LYMPH NODE ON LEFT SIDE OF NECK NEAR CLAVICLE; SORE ARM; TIREDNESS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 11:00 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced enlarged lymph node on left side of neck near clavicle. On APR-2021, the subject experienced sore arm. On APR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from enlarged lymph node on left side of neck near clavicle, sore arm, and tiredness. This report was non-serious.; Sender's Comments: V0: Medical assessment comments not required as per standard procedure as the case is considered non serious.
Administered expired Moderna vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered expired Moderna vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 068H21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered expired Moderna vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered expired Moderna vaccine) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. The HCP (health care professional) reported that an expired Moderna vaccine was administered to 36 patients from 15-Apr-2022 through 06-May-2022. The HCP confirmed no side effects were reported. No treatment medications were reported.
Patient was seen in a walk-in clinic on 2/1/20 Described as rash, erythema and induration in a large wheal greater than 4cm surrounding vaccination site with marked tenderness The walk-in clinic prescribed Atarax 25mg q8 PRN Kenalog ointment 0.1% ointment Keflex 500 mg BID for 7 days
2nd SHINGRIX shot on 11/29 at 10a. By evening, body aches, big as my fist, hot to touch. 12/1: very sore with same welt hot to touch, aching.
Patient received his first Covid vaccine shot on Friday, 8/6/21, at 1 pm.  On Saturday, 8/7/21, at approximately 11 am after waking up he began complaining   about his heart beating fast.  His normal heart rate is approximately 78, using a pulse ox, his heart rate at that time measured between 120--140.  By around 9 pm that the evening, his heart rate was measuring 115--120.  By the time he woke up the next morning, his heart rate was back down to normal at 80.  During this time the only other symptoms he had were a slight headache and fatigue.  No others.
Pt complained of throat closing up, tachycardia, dyspnea, swollen face, itching, HA, vertigo. No treatment, all symptoms showed the night of the shot & were gone next day. No rxn appears at site.
Dry mouth; Metal taste; Blood pressure high; Dizzy; Nausea; Weird sensation felt like water was running down her arm; Swollen arm/swelling left hand; Extreme thirst; Vertigo, swiminess; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo, swiminess), PARAESTHESIA (Weird sensation felt like water was running down her arm), PERIPHERAL SWELLING (Swollen arm/swelling left hand), THIRST (Extreme thirst) and DRY MOUTH (Dry mouth) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Aortic valve stenosis and insufficiency, Chronic sinusitis, Carpal tunnel syndrome and Mitral valve prolapse. Concurrent medical conditions included Hypertension, Kidney disorder, Migraine, Asthma, Type 2 diabetes mellitus and Stenosis. Concomitant products included TYRAMINE and MONOSODIUM GLUTAMATE for Migraine.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced VERTIGO (Vertigo, swiminess) and HEADACHE (Headache). On 22-Feb-2021, the patient experienced THIRST (Extreme thirst). On an unknown date, the patient experienced PARAESTHESIA (Weird sensation felt like water was running down her arm), PERIPHERAL SWELLING (Swollen arm/swelling left hand), DRY MOUTH (Dry mouth), DYSGEUSIA (Metal taste), HYPERTENSION (Blood pressure high), DIZZINESS (Dizzy) and NAUSEA (Nausea). At the time of the report, VERTIGO (Vertigo, swiminess), PARAESTHESIA (Weird sensation felt like water was running down her arm), PERIPHERAL SWELLING (Swollen arm/swelling left hand) and HEADACHE (Headache) had resolved and THIRST (Extreme thirst), DRY MOUTH (Dry mouth), DYSGEUSIA (Metal taste), HYPERTENSION (Blood pressure high), DIZZINESS (Dizzy) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Feb-2021, Blood glucose: increased (High) Increased. On 22-Feb-2021, Blood pressure measurement: high (High) blood pressure had risen.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 22Feb2021 patients cardiologist noticed that her blood pressure had risen and had to add a new medication and increase her existing one. No treatment information was provided.   This case was linked to MOD-2021-280076 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Aug-2021: Follow Up information was received on 25-Aug-2021 and events,relevant medical history and concomitant medications were added.
This spontaneous report was received from a physician and refers to a 71-year-old radiologist. No information about patient's concurrent conditions, concomitant medication and medical history was provided. On an unspecified date in 2009, the patient was vaccinated with the first dose of PNEUMOVAX 23 (dose, route of administration, lot# and expiration date not reported). The patient did not experience any adverse reaction following vaccination. On an unknown date, the patient was administer a booster dose of PNEUMOVAX 23. On an unknown date, 10 day after receiving the booster dose, the patient had an acute onset of pain with neuropathy (also reported as brachial plexus neuritis). The outcome of the event was not reported. The relatedness between PNEUMOVAX 23 and an acute onset of pain with neuropathy was not reported. Additional information has been requested.
Pt was here to receive his vaccination.  I went to give him the vaccine. I inserted the needle and began to inject.  Patient pulled away because it hurt to bad.  He was only given .3cc out of the .5cc that needed to be given.  Pt was very angry he had to get the vaccine in the first place.
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced influenza symptoms characterized by sever cough, and was treated with Ventalin. Approximately two months later the pt developed chickenpox consisting of one lesion on the forehead, two on the stomach, three on the back and one on his eyelid.
mosquito bite rash abd, arms, legs p/dose ! & 2 of hep b inj;
Patient received her second flu shot on 04/03/2023 at 0830. According to mother, next day morning she gave Tylenol and send baby day care. Day care called and informed mom that baby is fuzzy and refusing food. Mother brought infant home and baby vomited once. Around 9 pm baby started to develop generalized rashes on the abdomen, back, head and face. Baby was taken to ER , Benadryl given and discharged the same day.
I experienced a breakthrough case of COVID-19 with cough, headache, sinus pressure, aches in the neck and diarrhea.
pt recv vax 15JUN95 & JUL96 pt exp a fever & a full blown case of chickenpox over the entire body including the mucous membranes, vagina & perineal region;reporting MD did not consider the events to be adverse but consider  them vax failure
Vertigo (BPPV) - Treatment: Meclizine 25 mg, ondansetron, 4 mg.
approximately 3 inch red circle around injection site.  Slight itchiness and soreness at site.  Very slight swelling at site.
Scratchy, bloodshot eyes. Hot upper body. Cold lower body. Shooting pain left leg. Pain in lower right back. Numbness in hands/feet. Lightheaded/dizziness. Difficulty breathing.
Reactive airway symptoms post influenza vaccine shortness of breath, chest tightness, high pitched cough. Medication prescribed MEDROL dose pack, albuterol, BENADRYL.
Welts, lumps, redness, itching Hair loss, swollen face, soreness excruciating pain all over body and it still comes and goes I never healed yet, diarrhea stomach pain
Expired vaccine used/ administer expired vaccine to 450 patients, after the manufacture date of expiration.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ administer expired vaccine to 450 patients, after the manufacture date of expiration.) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ administer expired vaccine to 450 patients, after the manufacture date of expiration.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used/ administer expired vaccine to 450 patients, after the manufacture date of expiration.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications information was reported.  It was unknown if the vial was initially stored in the refrigerator. The vial did not undergo any temperature excursions.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Follow-up received included non-significant information.
Site: Bruising at Injection Site-Mild, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: Pt said the injection site has a little blister there and it broke and little swelling and also  a little brusing at the site. And also when pt is waiting for the 15minutes she felt tingling in her throat.
Mild discomfort on day one and two (friday, saturday). Sunday woke up to intense cough, headache and developed red itchy bumps on palms  and intensely spread head to toe throughout the day. Monday 10/10 at follow up rash was still head to toe but  12 cm x 10 cm raised hive hot to the touch over injection site on left arm.  and multiple similar sized hives on right arm, back and trunk had appeared. very uncomfortable with a notable uncomfortable wheeze and cough as well.
He has since been hospitalized multiple times for a heart arrhythmia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (RA). The reporter is the parent.  A 21-year-old male patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunisation; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunisation. The following information was reported: ARRHYTHMIA (hospitalization), outcome "unknown", described as "He has since been hospitalized multiple times for a heart arrhythmia". Clinical Course: Their son was a healthy 21 year old who received original COVID vaccine as well as the first booster 2 years ago. He had since been hospitalized multiple times for a heart arrhythmia. He did not have any health issues prior to receiving vaccine. He might need surgery to place an internal monitor.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
At the time of injection no issues other than sore arm. Day 9 post injection developed significant swelling, redness, warmth, and rash like irritation in left arm. Over the past 5 days there has been some decrease in swelling but the redness has formed a circle and has flare ups of rash, warm, and irritation. I have been taking benadyl, zyrtec, and cortisone cream to try and relieve symptoms.
Information has been received from a registered nurse concerning a 9 year old female who on February 14,1997 was vaccinated in the right arm with a first dose of varicella virus vaccine live (Oka/Merck) (Lot # 620614/1106D). During the week of December 19, 2005, the patient developed mild break through varicella. The patient presented with less than 50 lesions. Unspecified medical attention was sought and the patient recovered on an unspecified date. A product quality complaint was not involved. Follow up information was received from the registered nurse who reported that on December 20, 2005, the patient had multiple papules with red bare vesicles.  She was seen by the physician and it was most probably chickenpox diagnosed by the doctor. The patient subsequently recovered. No further information is expected.
Information has been received from a registered nurse concerning a 16 month old female patient with no previous medical history reported who on 01-APR-2009 was vaccinated with the first dose of MMR II (lot number not available) 0.5 mL SQ and concomitantly at the same time with DTaP (unspecified). On 01-APR-2009, the patient experienced redness and swelling at the site of MMR II administration. The patient also seemed to be in extreme pain during administration of the vaccine. The patient sought medical attention, saw at the practice. Additional information has been requested.
This case was reported by a nurse via call center representative and described the occurrence of injection site redness in a 17-year-old female patient who received BEXSERO (batch number 158701, expiry date 30th September 2017. On 2nd November 2016, the patient received BEXSERO. On 2nd November 2016, less than a day after receiving BEXSERO, the patient experienced injection site redness, injection site swelling and injection site pain. On an unknown date, the outcome of the injection site redness, injection site swelling and injection site pain were unknown. It was unknown if the reporter considered injection site redness, injection site swelling and pain to be related to BEXSERO. Additional details were provided as follows: The patient received a dose of BEXSERO and within 24 hours the patient experienced an injection site reaction, described as redness, swelling, and pain. The reporter has given the permission to contact again. It was reported that there was no seriousness criteria associated with event (hospitalisation and death). This is one of the 5 cases reported by the same reporter.
Patient developed shingles from getting vaccine, symptoms started day after getting vaccine. Symptoms involve rash and blisters on scalp, near eye and around mouth